PPARGC1A and hepatocellular carcinoma: In the present study, we found that, compound II downregulated the expressions of Sirt1 and PGC-1α, suggesting that the inhibitory effect of compound II on HCC may be related to regulate Sirt1/PGC-1α pathway.